Government

PRODUCTS

  • As your personal partner and pharma consulting expert, we sincerely understand the specific process and regulatory challenges of pharmaceutical, biotech, and medical device manufacturers in detail.

  • Legacy paper trails are a compliance nightmare.

    Missing documents, illegible handwriting, and inconsistent data leave you scrambling and vulnerable during audits. Digital CQV captures data and objective evidence in real time, ensuring a crystal-clear audit trail with time-stamped entries and electronic signatures that meet 21 CFR Part 11 requirements.

  • Precise, Complete, and Ultimate Detection.

    A premium dual energy x-ray inspection system offering outstanding detection of hard-to-find, low density contaminants, in a variety of applications. Available in standard and custom configurations

    Detect Hard-to-Find Contaminants

    Capable of detecting hard-to-find contaminants in a variety of applications. Offering clarity and precision in complex areas of product inspection.

    Enhance Product Quality

    Achieves outstanding product quality using advanced levels of foreign body detection of low-density contaminants in overlapping products.

    Increase Productivity

    Clever design combined with an intuitive user interface to create user-friendly systems that increase uptime and boost productivity.

  • Improve solubility, stability, and speed to clinic for even your toughest APIs. See why innovators are relying on Spray Dried Dispersion (SDD) technology.

  • IntegriCell™ cryopreservation services from Cryoport Systems optimize leukapheresis-derived cell therapies by enhancing the safety, quality, and viability of manufacture-ready cryopreserved leukopaks. Our state-of-the-art cryopreservation process, integrated with our end-to-end global temperature-controlled supply chain platform, provides unmatched reliability, efficiency, and scope. Our standardized protocols meet the highest compliance standards, ensuring consistent quality and addressing product stability issues associated with fresh donor-derived cellular material for an optimized approach that enhances manufacturing efficiency and streamlines operations.

WHITE PAPERS AND CASE STUDIES

NEWS